IRIS Accounts Production v23.1.0.753 11672554 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure116725542022-03-31116725542023-03-31116725542022-04-012023-03-31116725542021-03-31116725542021-04-012022-03-31116725542022-03-3111672554ns16:EnglandWales2022-04-012023-03-3111672554ns15:PoundSterling2022-04-012023-03-3111672554ns11:Director12022-04-012023-03-3111672554ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3111672554ns11:SmallEntities2022-04-012023-03-3111672554ns11:AuditExempt-NoAccountantsReport2022-04-012023-03-3111672554ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3111672554ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-3111672554ns11:FullAccounts2022-04-012023-03-3111672554ns11:OrdinaryShareClass12022-04-012023-03-3111672554ns11:Director22022-04-012023-03-3111672554ns11:RegisteredOffice2022-04-012023-03-3111672554ns6:CurrentFinancialInstruments2023-03-3111672554ns6:CurrentFinancialInstruments2022-03-3111672554ns6:ShareCapital2023-03-3111672554ns6:ShareCapital2022-03-3111672554ns6:FurtherSpecificReserve1ComponentTotalEquity2023-03-3111672554ns6:FurtherSpecificReserve1ComponentTotalEquity2022-03-3111672554ns6:RetainedEarningsAccumulatedLosses2023-03-3111672554ns6:RetainedEarningsAccumulatedLosses2022-03-3111672554ns6:FurnitureFittings2022-04-012023-03-3111672554ns6:ComputerEquipment2022-04-012023-03-3111672554ns6:LandBuildings2022-03-3111672554ns6:FurnitureFittings2022-03-3111672554ns6:ComputerEquipment2022-03-3111672554ns6:LandBuildings2022-04-012023-03-3111672554ns6:LandBuildings2023-03-3111672554ns6:FurnitureFittings2023-03-3111672554ns6:ComputerEquipment2023-03-3111672554ns6:LandBuildings2022-03-3111672554ns6:FurnitureFittings2022-03-3111672554ns6:ComputerEquipment2022-03-3111672554ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3111672554ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3111672554ns11:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: 11672554 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 MARCH 2023

FOR

H S PHARMA (BRISTOL) LTD

H S PHARMA (BRISTOL) LTD (REGISTERED NUMBER: 11672554)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023




Page

Company information 1

Balance sheet 2

Notes to the financial statements 3


H S PHARMA (BRISTOL) LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2023







Directors: A S Sadiq
H Sadiq





Registered office: 58 Flax Bourton Road
Falland
Bristol
United Kingdom
BS8 3UN





Registered number: 11672554 (England and Wales)





Accountants: Macalvins
7 St John's Road
Harrow
Middlesex
HA1 2EY

H S PHARMA (BRISTOL) LTD (REGISTERED NUMBER: 11672554)

BALANCE SHEET
31 MARCH 2023

2023 2022
Notes £    £   
Fixed assets
Tangible assets 4 243,825 230,825

Current assets
Stocks 62,500 72,500
Debtors 5 93,933 88,010
Cash at bank and in hand 100,056 178,311
256,489 338,821
Creditors
Amounts falling due within one year 6 (134,460 ) (185,653 )
Net current assets 122,029 153,168
Total assets less current liabilities 365,854 383,993

Capital and reserves
Called up share capital 7 1 1
Other reserves 336,084 336,084
Retained earnings 29,769 47,908
Shareholders' funds 365,854 383,993

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 7 November 2023 and were signed on its behalf by:





A S Sadiq - Director


H S PHARMA (BRISTOL) LTD (REGISTERED NUMBER: 11672554)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1. Statutory information

H S Pharma (Bristol) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. Accounting policies

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Previous year accounts is revised

Turnover
Revenue is recognised at an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring goods and services to the customer. Net of discounts and VAT.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on reducing balance
Office Equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. Employees and directors

The average number of employees during the year was 9 (2022 - 9 ) .

H S PHARMA (BRISTOL) LTD (REGISTERED NUMBER: 11672554)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023

4. Tangible fixed assets
Fixtures
Freehold and Office
property fittings Equipment Totals
£    £    £    £   
COST
At 1 April 2022 214,795 22,793 12,461 250,049
Additions 17,007 - - 17,007
At 31 March 2023 231,802 22,793 12,461 267,056
DEPRECIATION
At 1 April 2022 - 11,658 7,566 19,224
Charge for year - 2,783 1,224 4,007
At 31 March 2023 - 14,441 8,790 23,231
NET BOOK VALUE
At 31 March 2023 231,802 8,352 3,671 243,825
At 31 March 2022 214,795 11,135 4,895 230,825

5. Debtors: amounts falling due within one year
2023 2022
£    £   
Trade debtors 64,278 56,752
Amounts owed by associated company 459 359
VAT 18,720 10,433
Prepayments and accrued income 10,476 20,466
93,933 88,010

6. Creditors: amounts falling due within one year
2023 2022
£    £   
Trade creditors 123,385 164,140
Tax 3,435 13,208
Social security and other taxes 1,669 1,958
Directors' current accounts 173 193
Accruals and deferred income 5,798 6,154
134,460 185,653

7. Called up share capital


Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
1 Ordinary £1 1 1

H S PHARMA (BRISTOL) LTD (REGISTERED NUMBER: 11672554)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023

8. Related party disclosures

Included within other creditors is £173 (2022 : £193) an amount due from the directors of the company. There are no terms as to repayment of this balance.Included within other debtors is £459 (2022: £359) an amount due from H S Pharma Property Ltd, a company with virtue of common directorship